Osmoprep and Albuterol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Osmoprep (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate) and Albuterol (albuterol). Common drug interactions include lung disorder among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Osmoprep and Albuterol. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Osmoprep?

Osmoprep has active ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. It is often used in colonoscopy abnormal. eHealthMe is studying from 416 Osmoprep users. Check the latest studies of Osmoprep.

What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,053 Albuterol users. Check the latest studies of Albuterol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

14 people who take Osmoprep and Albuterol together, and have interactions are studied.

Osmoprep and Albuterol drug interactions.

What are the common drug interactions of Osmoprep and Albuterol, by gender? *:

female:

  1. Lung disorder (lung disease)
  2. Skin burning sensation
  3. Chronic kidney disease
  4. Kidney infection
  5. Pulmonary congestion (congestion in the lungs)
  6. Renal failure (kidney dysfunction)
  7. Abdominal discomfort
  8. Alopecia (absence of hair from areas of the body)
  9. Blood cholesterol increased
  10. Cough

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hypokalaemia (low potassium)
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Occult blood positive
  6. Pain
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Pneumonia
  9. Renal failure acute (rapid kidney dysfunction)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Osmoprep and Albuterol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Kidney infection
  3. Malignant melanoma (skin cancer rises from melancytes)
  4. Renal failure (kidney dysfunction)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hypokalaemia (low potassium)
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Occult blood positive
  6. Pain
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Pneumonia
  9. Renal failure acute (rapid kidney dysfunction)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 28.57%
  2. Cystic Fibrosis (disease of the secretary glands): 3 people, 21.43%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
  4. High Blood Pressure: 3 people, 21.43%
  5. Upper Respiratory Tract Infection: 2 people, 14.29%
  6. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 14.29%
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 14.29%
  8. Dry Eyes (lack of adequate tears): 2 people, 14.29%
  9. Dyspnea (difficult or laboured breathing): 2 people, 14.29%
  10. Eye Inflammation: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Osmoprep and Albuterol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Osmoprep and Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Osmoprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Osmoprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Albuterol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate and albuterol (the active ingredients of Osmoprep and Albuterol, respectively), and Osmoprep and Albuterol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: